Capsule
NOSCOFED-NF CAP
Summary
NOSCOFED-NF CAP — Capsule containing bromhexine hydrochloride, caffeine, chlorphenamine maleate, lysozyme hydrochloride, paracetamol, pentoxyverine citrate, phenylephrine hydrochloride. Hong Kong Registration No. HK-54473. Certificate Holder: KAREN LABORATORIES O/B KAREN PHARMACEUTICAL CO LTD. Date of Registration: 15 Jul, 2006.
Product NameNOSCOFED-NF CAP
Registration No.HK-54473
Certificate HolderKAREN LABORATORIES O/B KAREN PHARMACEUTICAL CO LTD
Holder Address1AB & 17B, SUCCESS INDUSTRIAL BUILDING, 7 KIN FAT STREET, TUEN MUN, NEW TERRITORIES
Ingredientsbromhexine hydrochloride, caffeine, chlorphenamine maleate, lysozyme hydrochloride, paracetamol, pentoxyverine citrate, phenylephrine hydrochloride
Dosage FormCapsule
Legal ClassificationPart 2 Poison
Sale RequirementOver-The-Counter Medicines
Date of Registration15 Jul, 2006
ATC codesC01CA06, C05AX06, D06BB07, D11AX26, J05AX02, N02BE01, N06BC01, R01AA04, R01AB01, R01BA03, R05CB02, R05DB05, R06AB04, S01FB01, S01GA05
ATC Classification
ATC level 1
C Cardiovascular System / D Dermatologicals / J Antiinfectives for Systemic Use / N Nervous System / R Respiratory System / S Sensory Organs
All ATC groupsC01, C05, D06, D11, J05, N02, N06, R01, R05, R06, S01
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。